Categories AlphaGraphs, Earnings, Retail

PepsiCo edges past market estimates in Q2

Beverage giant PepsiCo (NASDAQ: PEP) on Tuesday reported second-quarter earnings and revenues that topped earnings estimates. Revenues grew 2.2% to $16.45 billion, edging past analysts’ estimate for $16.42 billion. On an organic basis, revenue grew 4.5%.

The snack business continued to outperform in Q2, with organic revenue growth of 5%. The segment was also returned 4.5% higher adjusted constant currency profits. Meanwhile, the Quaker Foods North America, despite seeing a 3% organic revenue growth, saw its profits plunge double-digits.  

PepsiCo Q2 2019 earnings infographic

Core earnings fell 4.3% year-over-year to $1.54 per share, beating the street estimate of $1.50 per share.

PEP shares were up 0.5% during pre-market trading on Tuesday. The stock has gained 22% so far this year.

Ramon Laguarta, who took charge as PepsiCo CEO in October last year, expressed confidence of meeting the full-year targets set by the beverage company.

READ: Why is it the right time to invest in beverage stocks?

PepsiCo reiterated its guidance of full-year organic revenue growth of 4%. For this period, core EPS is projected to fall 3% to $5.50 per share.

PepsiCo continues to boost its strong product portfolio through innovation and strategic partnerships. The company recently teamed up with Lavazza to launch iced coffee in the UK. PepsiCo’s diversification efforts through various acquisitions and partnerships are likely to pay off in driving growth going forward.

Pepsi’s primary competitor The Coca Cola Company (NYSE: KO) is slated to report financial results two weeks later.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Also Read:  Hexo stock plunges to a new low after reporting preliminary Q4 results; withdraws FY20 outlook

Most Popular

BlackBerry (BB) likely to report weak Q4 earnings on March 31

BlackBerry Limited (NYSE: BB) is slated to report its fourth-quarter 2020 earnings results on Tuesday, March 31, after the market closes. The top line will be benefited by BlackBerry Cylance

Companies that are working on the coronavirus vaccine

The coronavirus pandemic continues to plague the world with over 500,000 cases reported globally and over 82,000 cases in the US alone. As the world grapples with the outbreak, several

Altimmune (ALT) reports FY19 results; announces vaccine candidate for COVID-19

Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last year. The drop in revenues was caused by lower billings

One thought on “PepsiCo edges past market estimates in Q2

Comments are closed.

Tags